T2 relaxation time of the normal-appearing white matter is related to the cognitive status in cerebral small vessel disease. Issue 7 (July 2021)
- Record Type:
- Journal Article
- Title:
- T2 relaxation time of the normal-appearing white matter is related to the cognitive status in cerebral small vessel disease. Issue 7 (July 2021)
- Main Title:
- T2 relaxation time of the normal-appearing white matter is related to the cognitive status in cerebral small vessel disease
- Authors:
- Brandhofe, Annemarie
Stratmann, Christoph
Schüre, Jan-Rüdiger
Pilatus, Ulrich
Hattingen, Elke
Deichmann, Ralf
Nöth, Ulrike
Wagner, Marlies
Gracien, René-Maxime
Seiler, Alexander - Abstract:
- Previous diffusion tensor imaging (DTI) studies indicate that impaired microstructural integrity of the normal-appearing white matter (NAWM) is related to cognitive impairment in cerebral small vessel disease (SVD). This study aimed to investigate whether quantitative T2 relaxometry is a suitable imaging biomarker for the assessment of tissue changes related to cognitive abnormalities in patients with SVD. 39 patients and 18 age-matched healthy control subjects underwent 3 T magnetic resonance imaging (MRI) with T2-weighted multiple spin echo sequences for T2 relaxometry and DTI sequences, as well as comprehensive cognitive assessment. Averaged quantitative T2, fractional anisotropy (FA) and mean diffusivity (MD) were determined in the NAWM and related to cognitive parameters controlling for age, normalized brain volume, white matter hyperintensity volume and other conventional SVD markers. In SVD patients, quantitative T2 values were significantly increased compared to controls (p = 0.002) and significantly negatively correlated with the global cognitive performance (r= –0.410, p = 0.014) and executive function (r= –0.399, p = 0.016). DTI parameters did not correlate with cognitive function. T2 relaxometry of the NAWM seems to be sensitive to microstructural tissue damage associated with cognitive impairment in SVD and might be a promising imaging biomarker for evaluation of disease progression and possible effects of therapeutic interventions.
- Is Part Of:
- Journal of cerebral blood flow & metabolism. Volume 41:Issue 7(2021)
- Journal:
- Journal of cerebral blood flow & metabolism
- Issue:
- Volume 41:Issue 7(2021)
- Issue Display:
- Volume 41, Issue 7 (2021)
- Year:
- 2021
- Volume:
- 41
- Issue:
- 7
- Issue Sort Value:
- 2021-0041-0007-0000
- Page Start:
- 1767
- Page End:
- 1777
- Publication Date:
- 2021-07
- Subjects:
- cognitive impairment -- microstructure -- quantitative imaging -- small vessel disease -- white matter
Cerebral circulation -- Periodicals
Brain -- Metabolism -- Periodicals
Brain -- Blood-vessels -- Periodicals
Cerebrovascular disease -- Periodicals
612.824 - Journal URLs:
- http://jcb.sagepub.com/ ↗
http://136.142.56.160/ovidweb/ovidweb.cgi?T=JS&MODE=ovid&NEWS=N&PAGE=toc&D=ovid%5fovft&AN=00004647-000000000-00000 ↗
http://www.jcbfm.com ↗
http://www.nature.com/jcbfm/index.html ↗
http://www.nature.com/ ↗ - DOI:
- 10.1177/0271678X20972511 ↗
- Languages:
- English
- ISSNs:
- 0271-678X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4955.110000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15839.xml